Prevalence of significant genetic variants in congenital long QT syndrome is largely underestimated

Frontiers in Pharmacology

Volumn 3 APR, Issue , 2012, Pages

  Zaklyazminskaya, Elena V ^a   Abriel, Hugues ^b  

^a PETROVSKY NATIONAL RESEARCH CENTER OF SURGERY   (Russian Federation)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL; ION CHANNEL REGULATORY PROTEIN; POTASSIUM CHANNEL KCNQ1; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; DISEASE TRANSMISSION; DNA DETERMINATION; ETHNIC DIFFERENCE; FINLAND; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; HEART ARRHYTHMIA; HETEROZYGOTE; HUMAN; LONG QT SYNDROME; MOLECULAR DIAGNOSIS; NORWAY; PENETRANCE; PREVALENCE; PROTEIN SUBUNIT; RARE DISEASE; SAMPLE SIZE;

EID: 84866039750     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00072     Document Type: Article

References (25)

1. Berge, K. E., Haugaa, K. H., Früh, A., Anfinsen, O. G., Gjesdal, K., Siem, G., Oyen, N., Greve, G., Carlsson, A., Rognum, T. O., Hallerud, M., Kongsgård, E., Amlie, J. P., and Leren, T. P. (2008). Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers'. Scand. J. Clin. Lab. Invest. 68:5, 362-368.
2. Bezzina, C. R., Rook, M. B., Groenewegen, W. A., Herfst, L. J., van der Wal, A. C., Lam, J., Jongsma, H. J., Wilde, A. A., and Mannens, M. M. (2003). Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ. Res. 92, 159-168.
3. Brink, P. A., Crotti, L., Corfield, V., Goosen, A., Durrheim, G., Hedley, P., Heradien, M., Geldenhuys, G., Vanoli, E., Bacchini, S., Spazzolini, C., Lundquist, A. L., Roden, D. M., George, A. L. Jr., and Schwartz, P. J. (2005). Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation 112, 2602-2610.
4. Daubert, J. P., Zareba, W., Rosero, S. Z., Budzikowski, A., Robinson, J. L., and Moss, A. J. (2007). Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am. Heart J. 153(Suppl.), 53-58.
5. Fodstad, H., Bendahhou, S., Rougier, J. S., Laitinen-Forsblom, P. J., Barhanin, J., Abriel, H., Schild, L., Kontula, K., and Swan, H. (2006). Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients. Ann. Med. 38, 294-304.
6. Goldenberg, I., Zareba, W., and Moss, A. J. (2008). Long QT syndrome. Curr. Probl. Cardiol. 33, 629-694.
7. Gouas, L., Bellocq, C., Berthet, M., Potet, F., Demolombe, S., Forhan, A., Lescasse, R., Simon, F., Balkau, B., Denjoy, I., Hainque, B., Baró, I., and Guicheney, P. (2004). New KCNQ1 mutations leading to haploinsufficiency in a general population. Defective trafficking of a KvLQT1 mutant. Cardiovasc. Res. 63, 60-68.
8. Itoh, H., Shimizu, W., Hayashi, K., Yamagata, K., Sakaguchi, T., Ohno, S., Makiyama, T., Akao, M., Ai, T., Noda, T., Miyazaki, A., Miyamoto, Y., Yamagishi, M., Kamakura, S., and Horie, M. (2010). Long QT syndrome with compound mutations is associatedwith a more severe phenotype: a Japanese multicenter study. Heart Rhythm 7, 1411-1418.
9. Kapplinger, J. D., Tester, D. J., Salisbury, B. A., Carr, J. L., Harris-Kerr, C., Pollevick, G. D., Wilde, K. K., and Ackerman, M. J. (2009). Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm 6, 1297-1303.
10. Marjamaa, A., Salomaa, V., Newton-Cheh, C., Porthan, K., Reunanen, A., Karanko, H., Jula, A., Lahermo, P., Väänänen, H., Toivonen, L., Swan, H., Viitasalo, M., Nieminen, M. S., Peltonen, L., Oikarinen, L., Palotie, A., and Kontula, K. (2009). High prevalence of long QT syndrome founder mutations in the Finnish population. Ann. Med. 10, 12.
11. Miller, T. E., Estrella, E., Myerburg, R. J., Garcia de Viera, J., Moreno, N., Rusconi, P., Ahearn, M. E., Baumbach, L., Kurlansky, P., Wolff, G., and Bishopric, N. H. (2004). Recurrent third-trimester fetal loss and maternal mosaicism for long-QT syndrome. Circulation 109, 3029-3034.
12. Nishio, Y., Makiyama, T., Itoh, H., Sakaguchi, T., Ohno, S., Gong, Y. S., Yamamoto, S., Ozawa, T., Ding, W. G., Toyoda, F., Kawamura, M., Akao, M., Matsuura, H., Kimura, T., Kita, T., and Horie, M. (2009). D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. J. Am. Coll. Cardiol. 54, 812-819.
13. Priori, S., Napolitano, C., and Schwartz, P. (1999). Low penetrance in the long-QT syndrome: clinical impact. Circulation 99, 529-533.
14. Priori, S., Napolitano, C., and Schwartz, P. (2008). "Genetics of cardiac arrhythmias," in Braunwald's Heart Disease, 8th Edn, eds P. Libby, R. O. Bonow,D. L. Mann, and D. P. Zipes (Philadelphia: Saunders Elsevier), 101-110.
15. Refsgaard, L., Holst, A., Sadijadieh, G., Haunsø, S., Nielsen, J., and Olesen, M. (2012). High prevalence of genetic variants previously associated with LQT syndrome in new exome data. Eur. J. Hum. Genet. PMID: 22378279. [Epub ahead of print].
16. Richter, S., and Brugada, P. (2006). Risk-stratifying Jervell and Lange-Nielsen syndrome from clinical data. J. Cardiovasc. Electrophysiol. 17, 1169-1171.
17. Roden, D. M., and Spooner, P. M. (1999). Inherited long QT syndromes: a paradigm for understanding arrhythmogenesis. J. Cardiovasc. Electrophysiol. 10, 1664-1683.
18. Schwartz, P. J., Stramba-Badiale, M., Crotti, L., Pedrazzini, M., Besana, A., Bosi, G., Gabbarini, F., Goulene, K., Insolia, R., Mannarino, S., Mosca, F., Nespoli, L., Rimini, A., Rosati, E., Salice, P., and Spazzolini, C. (2009). Prevalence of the congenital long-QT syndrome. Circulation 120, 1761-1767.
19. Sesti, F., Abbott, G. W., Wei, J., Murray, K. T., Saksena, S., Schwartz, P. J., Priori, S. G., Roden, D. M., George, A. L. Jr., and Goldstein, S. A. (2000). A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc. Natl. Acad. Sci. U.S.A. 97, 10613-10618.
20. Shinlapawittayatorn, K., Du, X. X., Liu, H., Ficker, E., Kaufman, E. S., and Deschênes, I. (2011). A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations. Heart Rhythm 8, 455-462.
21. Splawski, I., Shen, J., Timothy, K. W., Lehmann, M. H., Priori, S., Robinson, J. L., Moss, A. J., Schwartz, P. J., Towbin, J. A., Vincent, G. M., and Keating, M. T. (2000). Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102, 1178-1185.
22. Tester, D. J., Cronk, L. B, Carr, J. L., Schulz, V., Salisbury, B. A., Judson, R. S., and Ackerman, M. J. (2006). Allelic dropout in long QT syndrome genetic testing: a possible mechanism underlying false-negative results. Heart Rhythm 3, 815-821.
23. Vogel, F., and Motulsky, A. G. (1986). Human Genetics. Problems and Approaches, 2nd Edn, Vol. 1. Berlin: Springer-Verlag.
24. Webster, G., and Berul, C. I. (2008). Congenital long-QT syndromes: a clinical and genetic update from infancy through adulthood. Trends Cardiovasc. Med. 18, 216-224.
25. Westenskow, P., Splawski, I., Timothy, K., Keating, M. T., and Sanguinetti, M. C. (2004). Compound mutations a common cause of severe long-QT syndrome. Circulation 109, 1834-1841.